Vimta Labs

Market Cap: Small Cap
Industry: Medical Equipment/Supplies/Accessories
ISIN: INE579C01029
NSEID: VIMTALABS
BSEID: 524394

INR

924.25

64.3 (7.48%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.23 lacs

Click here to access the older version

Company CV

About Vimta Labs Ltd

Vimta Labs Ltd

Small Cap

Medical Equipment/Supplies/Accessories

Vimta Labs Ltd., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries.

Company Coordinates

Company Details

Plot No 141/2 & 142, IDA Phase II Cherlapally Hyderabad Telangana : 500051

Tel: 91-40-27264141

http://www.vimta.com

shares@vimta.com

Registrar Details

Cil Securities Ltd , 214 Raghava Ratna Towers , Chirag Ali Lane, Abidas, Hyderabad

Capital Structure

Present Equity Capital

INR 4.43 Cr

Number of Shares

2.22 Cr

Face Value

INR 2.0

Date

Number
of Shares(Cr)

Equity
Capital (Rs Cr)

Shares Added

Face Value (Rs)

Reason

28-Feb-2024

2.22

4.43

5218

Issued under ESOP Scheme

17-Nov-2023

2.22

4.43

18018

Issued under ESOP Scheme

21-Sep-2023

2.21

4.43

4268

Issued under ESOP Scheme

25-Jul-2023

2.21

4.43

4530

Issued under ESOP Scheme

25-Apr-2023

2.21

4.43

9560

Issued under ESOP Scheme

14-Feb-2023

2.21

4.43

6160

Issued under ESOP Scheme

29-Nov-2022

2.21

4.42

5056

Issued under ESOP Scheme

11-Oct-2022

2.21

4.42

9963

Issued under ESOP Scheme

11-Oct-2022

2.21

4.42

9963

Issued under ESOP Scheme

Shareholding

Shareholding Snapshot

Shareholding Compare (%holding)

Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 3 Schemes (0.13%)

FIIs

Held by 28 FIIs (3.81%)

Promoter with highest holding

Sivalinga Prasad Vasireddi (11.7%)

Highest Public shareholder

Eurofins Analytical Services India Pvt Ltd (19.82%)

Individual Investors Holdings

25.09%

Board of Directors

Period

Management

Designation

Remuneration

S P Vasireddi

Executive Chairman

V Harriman

Director (Operation)

1.59 cr

Harita Vasireddi

Managing Director

1.64 cr

Y Prameela Rani

Non-Exec. & Independent Dir.

2.0 lacs

Sujani Vasireddi

Company Sec. & Compli. Officer

G Purnachandra Rao

Non-Exec. & Independent Dir.

2.0 lacs

Sanjay Dave

Non-Exec. & Independent Dir.

2.0 lacs

Satya Sreenivas Neerukonda

Executive Director

1.52 cr

Yadagiri R Pendri

Non-Exec. & Independent Dir.

Raw Materials

Raw Materials Dashboard

Raw Materials

Amount(Rs Cr)

% of RM Cost

Raw material consumed

44.133

Raw material consumed

Finished Goods

Finished Goods Dashboard

Finished Goods

Amount(Rs Cr)

% of Sales Turnover

Sale of Services - Testing & Analysis

207.96

97.80%

Other Operating Revenue - Export Incentives

4.68

2.20%

Sale of Services - Testing & Analysis

Other Operating Revenue - Export Incentives

Stock DNA

Revenue and Profits:

Net Sales:

90 Cr

(Quarterly Results - Dec 2024)

Net Profit:

22 Cr

Industry

Medical Equipment/Supplies/Accessories

Market cap

INR 2,055 Cr (Small Cap)

P/E

31.00

Industry P/E

Dividend Yield

0.23%

Debt Equity

-0.05

Return on Equity

15.84%

Price to Book

5.58